HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A Single-Nucleotide Polymorphism Upstream of the HLA-C Locus Is Associated With an Anti-Hepatitis C Virus-Seronegative State in a High-Risk Exposed Cohort.

Abstract
In this study, we examined the impact of the rs9264942 single-nucleotide polymorphism, previously shown to be associated with human immunodeficiency virus infection status and HLA-C expression, on the hepatitis C virus status in 359 people who inject drugs (PWID). The linkage of rs9264942 alleles to HLA-C antigens assigned to different expression levels was confirmed. Multivariate analysis revealed the age (P = .003) and the rs9264942 genotype (P = .006) to be independent factors for the classification to the PWID groups. Our study showed that the presence of the rs9264942 C/C genotype was associated with persistent seronegativity.
AuthorsChristine Thoens, Andreas Heinold, Monika Lindemann, Peter A Horn, Dae-In Chang, Norbert Scherbaum, Joerg Timm, Falko M Heinemann
JournalThe Journal of infectious diseases (J Infect Dis) Vol. 218 Issue 12 Pg. 2016-2019 (11 05 2018) ISSN: 1537-6613 [Electronic] United States
PMID30102364 (Publication Type: Journal Article)
Chemical References
  • Antibodies, Viral
  • HLA-C Antigens
  • RNA, Viral
Topics
  • Adolescent
  • Adult
  • Aged
  • Antibodies, Viral (blood)
  • Cohort Studies
  • Female
  • Genetic Predisposition to Disease
  • Genotype
  • HLA-C Antigens (genetics)
  • Hepacivirus (genetics)
  • Hepatitis C (etiology, genetics, immunology)
  • Humans
  • Male
  • Middle Aged
  • Polymorphism, Single Nucleotide
  • RNA, Viral (isolation & purification)
  • Risk Factors
  • Substance Abuse, Intravenous (complications)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: